Auris Medical Holding Overview

Auris Medical Holding Research & Development

Research & Development expenses for EARS.

Quarterly R&D Expenses

$1.13M

↓ 36.55% YoY

As of Jun 30, 2023

Annual R&D Expenses (TTM)

$13.32M

↑ 52.7% YoY

Trailing 12 months ending Jun 30, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin